• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子2 mRNA结合蛋白2通过低氧诱导因子1α介导的糖酵解调节胃癌放疗抗性。

IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis.

作者信息

Zhang Qi, Liu Xiaoyu, Chen Yukan, Wang Ruilin, Zhao Shuangyan, Tian Yuting, Li Shuping, Liu Xiaojun

机构信息

The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, Gansu, China.

Xi'an International Medical Center Hospital, Xian, Shanxi, China.

出版信息

Front Oncol. 2025 May 16;15:1512177. doi: 10.3389/fonc.2025.1512177. eCollection 2025.

DOI:10.3389/fonc.2025.1512177
PMID:40469197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12134386/
Abstract

This study reveals the core mechanism by which insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) drives tumor progression and radiotherapy resistance in gastric cancer (GC) through mA-dependent regulation of hypoxia-inducible factor 1α (HIF1α). Clinical analyses show that IGF2BP2 is significantly overexpressed in gastric cancer tissues, and its expression level is closely associated with tumor size and poor patient prognosis. Functional studies demonstrate that elevated expression of IGF2BP2 accelerates the transition of gastric cancer cells from the G1 phase to the G2/M phase of the cell cycle and markedly enhances cell proliferation and migration through anti-apoptotic effects. Mechanistically, IGF2BP2 specifically binds to the mA-modified "GGACU" motif within the coding region of HIF1α mRNA, positively regulating HIF1α mRNA stability and protein expression in an mA-dependent manner. High IGF2BP2 expression significantly enhances glycolytic activity in gastric cancer cells, while overexpression of HIF1α partially rescues the suppression of malignant phenotypes caused by IGF2BP2 knockdown, indicating that HIF1α serves as a key downstream effector mediating the oncogenic role of IGF2BP2 in gastric cancer. Furthermore, knockdown of IGF2BP2 significantly increases radiosensitivity by exacerbating DNA damage and enhancing oxidative stress.

摘要

本研究揭示了胰岛素样生长因子2信使核糖核酸结合蛋白2(IGF2BP2)通过对缺氧诱导因子1α(HIF1α)的N6-甲基腺嘌呤(m⁶A)依赖性调控来驱动胃癌(GC)肿瘤进展和放疗抵抗的核心机制。临床分析表明,IGF2BP2在胃癌组织中显著过表达,其表达水平与肿瘤大小及患者预后不良密切相关。功能研究表明,IGF2BP2表达升高加速胃癌细胞从细胞周期的G1期向G2/M期转变,并通过抗凋亡作用显著增强细胞增殖和迁移。机制上,IGF2BP2特异性结合HIF1α信使核糖核酸编码区内m⁶A修饰的“GGACU”基序,以m⁶A依赖性方式正向调节HIF1α信使核糖核酸稳定性和蛋白表达。高IGF2BP2表达显著增强胃癌细胞的糖酵解活性,而HIF1α过表达部分挽救了因IGF2BP2敲低导致的恶性表型抑制,表明HIF1α作为关键的下游效应因子介导IGF2BP2在胃癌中的致癌作用。此外,敲低IGF2BP2通过加剧DNA损伤和增强氧化应激显著增加放射敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/7ae2632f3eaa/fonc-15-1512177-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/875f587cceba/fonc-15-1512177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/0d8f559453d2/fonc-15-1512177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/78bf8278ecc0/fonc-15-1512177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/96f9df86bc6b/fonc-15-1512177-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/9c3b9df426d3/fonc-15-1512177-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/eef36c8e868c/fonc-15-1512177-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/7ae2632f3eaa/fonc-15-1512177-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/875f587cceba/fonc-15-1512177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/0d8f559453d2/fonc-15-1512177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/78bf8278ecc0/fonc-15-1512177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/96f9df86bc6b/fonc-15-1512177-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/9c3b9df426d3/fonc-15-1512177-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/eef36c8e868c/fonc-15-1512177-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12134386/7ae2632f3eaa/fonc-15-1512177-g007.jpg

相似文献

1
IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis.胰岛素样生长因子2 mRNA结合蛋白2通过低氧诱导因子1α介导的糖酵解调节胃癌放疗抗性。
Front Oncol. 2025 May 16;15:1512177. doi: 10.3389/fonc.2025.1512177. eCollection 2025.
2
Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 (IGF2BP2) Promotes Castration-Resistant Prostate Cancer Progression by Regulating AR-V7 mRNA Stability.胰岛素样生长因子2信使核糖核酸结合蛋白2(IGF2BP2)通过调节AR-V7信使核糖核酸稳定性促进去势抵抗性前列腺癌进展。
Cancer Rep (Hoboken). 2025 Feb;8(2):e70096. doi: 10.1002/cnr2.70096.
3
Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.组蛋白甲基转移酶 SETD1A 与 HIF1α 相互作用,增强糖酵解,促进胃癌的癌症进展。
Mol Oncol. 2020 Jun;14(6):1397-1409. doi: 10.1002/1878-0261.12689. Epub 2020 Apr 26.
4
Replication factor C4, which is regulated by insulin-like growth factor 2 mRNA binding protein 2, enhances the radioresistance of breast cancer by promoting the stemness of tumor cells.复制因子C4受胰岛素样生长因子2 mRNA结合蛋白2调控,通过促进肿瘤细胞的干性增强乳腺癌的放射抗性。
Hum Cell. 2025 Mar 7;38(3):65. doi: 10.1007/s13577-025-01197-9.
5
N-methyladenosine (mA) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1.N-甲基腺苷(mA)阅读器IGF2BP2通过靶向沉默调节蛋白1(SIRT1)促进胃癌进展。
Bioengineered. 2022 May;13(5):11541-11550. doi: 10.1080/21655979.2022.2068920.
6
HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification.HES1通过IGF2BP2介导的GLUT1 m6A修饰促进结直肠癌的有氧糖酵解和癌症进展。
Cell Death Discov. 2023 Nov 13;9(1):411. doi: 10.1038/s41420-023-01707-4.
7
RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.RNA N6-甲基腺嘌呤阅读器 IGF2BP2 通过依赖 m6A 的方式稳定 slug mRNA,促进头颈部鳞状细胞癌细胞的淋巴转移和上皮-间充质转化。
J Exp Clin Cancer Res. 2022 Jan 3;41(1):6. doi: 10.1186/s13046-021-02212-1.
8
mA reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability.毫安读数器IGF2BP2稳定的CASC9通过增强HK2 mRNA稳定性加速胶质母细胞瘤有氧糖酵解。
Cell Death Discov. 2021 Oct 13;7(1):292. doi: 10.1038/s41420-021-00674-y.
9
FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.FBW7/GSK3β 介导的 IGF2BP2 降解抑制了肺癌中 IGF2BP2-SLC7A5 正反馈环和放射抵抗。
J Exp Clin Cancer Res. 2024 Jan 29;43(1):34. doi: 10.1186/s13046-024-02959-3.
10
The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.m6A 阅读器 IGF2BP2 通过增加 OCT4 mRNA 的稳定性促进食管鳞状细胞癌细胞的进展。
Biochem Cell Biol. 2024 Apr 1;102(2):169-178. doi: 10.1139/bcb-2023-0067. Epub 2023 Nov 2.

本文引用的文献

1
The role of m6A methylation in therapy resistance in cancer.m6A 甲基化在癌症治疗抵抗中的作用。
Mol Cancer. 2023 Jun 1;22(1):91. doi: 10.1186/s12943-023-01782-2.
2
N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.N6-甲基腺苷修饰的SUV39H2通过对胃癌中DUSP6的表观遗传抑制来调节同源重组。
Cancer Lett. 2023 Apr 1;558:216092. doi: 10.1016/j.canlet.2023.216092. Epub 2023 Feb 15.
3
The mA reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia.
mA 阅读器 IGF2BP2 调节谷氨酰胺代谢,是急性髓系白血病的治疗靶点。
Cancer Cell. 2022 Dec 12;40(12):1566-1582.e10. doi: 10.1016/j.ccell.2022.10.004. Epub 2022 Oct 27.
4
RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications.RM2Target:一个全面的数据库,用于 RNA 修饰的写入器、擦除器和读取器的靶标。
Nucleic Acids Res. 2023 Jan 6;51(D1):D269-D279. doi: 10.1093/nar/gkac945.
5
Signaling pathways and therapeutic interventions in gastric cancer.胃癌中的信号通路和治疗干预措施。
Signal Transduct Target Ther. 2022 Oct 8;7(1):358. doi: 10.1038/s41392-022-01190-w.
6
A deep learning model (FociRad) for automated detection of γ-H2AX foci and radiation dose estimation.一种用于自动检测 γ-H2AX 焦点和辐射剂量估计的深度学习模型(FociRad)。
Sci Rep. 2022 Apr 1;12(1):5527. doi: 10.1038/s41598-022-09180-2.
7
HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer.缺氧诱导因子-1α 抑制促进免疫检查点阻断在非小细胞肺癌治疗中的疗效。
Cancer Lett. 2022 Apr 10;531:39-56. doi: 10.1016/j.canlet.2022.01.027. Epub 2022 Jan 26.
8
MiRNA-4537 functions as a tumor suppressor in gastric cancer and increases the radiosensitivity of gastric cancer cells.miRNA-4537 在胃癌中作为一种肿瘤抑制因子发挥作用,并提高胃癌细胞的放射敏感性。
Bioengineered. 2021 Dec;12(1):8457-8467. doi: 10.1080/21655979.2021.1982843.
9
SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.SUMOylation 修饰 IGF2BP2 通过调控 OIP5-AS1/miR-495-3p 轴促进胶质瘤血管生成拟态。
Int J Biol Sci. 2021 Jul 13;17(11):2912-2930. doi: 10.7150/ijbs.58035. eCollection 2021.
10
Pan-cancer analysis of clinical significance and associated molecular features of glycolysis.泛癌症分析糖酵解的临床意义及相关分子特征。
Bioengineered. 2021 Dec;12(1):4233-4246. doi: 10.1080/21655979.2021.1955510.